Citadel Advisors
ANGO icon

Citadel Advisors’s AngioDynamics ANGO Stock Holding History

Citadel Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$549K Sell
48,322
-2,561
-5% -$27.8K ﹤0.01% 9069
2025
Q4 		$653K Buy
+50,883
New +$628K ﹤0.01% 8366
2025
Q2 		– Sell
-202,916
Closed -$1.99M – 12409
2025
Q1 		$1.91M Sell
202,916
-612,910
-75% -$6.44M ﹤0.01% 5626
2024
Q4 		$7.47M Buy
815,826
+632,376
+345% +$4.65M ﹤0.01% 3354
2024
Q3 		$1.43M Buy
183,450
+25,799
+16% +$186K ﹤0.01% 6160
2024
Q2 		$954K Sell
157,651
-693,852
-81% -$4.28M ﹤0.01% 6680
2024
Q1 		$5M Sell
851,503
-162,273
-16% -$964K ﹤0.01% 3953
2023
Q4 		$7.95M Buy
1,013,776
+3,579
+0.4% +$24.8K ﹤0.01% 3144
2023
Q3 		$7.38M Buy
1,010,197
+470,975
+87% +$3.92M ﹤0.01% 3082
2023
Q2 		$5.62M Buy
539,222
+117,656
+28% +$1.13M ﹤0.01% 3471
2023
Q1 		$4.36M Buy
421,566
+5,907
+1% +$75.6K ﹤0.01% 4033
2022
Q4 		$5.72M Buy
415,659
+236,301
+132% +$3.29M ﹤0.01% 3633
2022
Q3 		$3.67M Sell
179,358
-86,524
-33% -$1.9M ﹤0.01% 4410
2022
Q2 		$5.14M Buy
265,882
+46,937
+21% +$961K ﹤0.01% 3739
2022
Q1 		$4.72M Buy
218,945
+201,220
+1,135% +$4.57M ﹤0.01% 4283
2021
Q4 		$489K Sell
17,725
-20,166
-53% -$556K ﹤0.01% 9751
2021
Q3 		$983K Sell
37,891
-30,753
-45% -$822K ﹤0.01% 8199
2021
Q2 		$1.86M Sell
68,644
-27,214
-28% -$665K ﹤0.01% 6785
2021
Q1 		$2.24M Buy
95,858
+3,361
+4% +$67.9K ﹤0.01% 6119
2020
Q4 		$1.42M Buy
92,497
+3,017
+3% +$38.3K ﹤0.01% 6066
2020
Q3 		$1.08M Buy
+89,480
New +$849K ﹤0.01% 5901
2019
Q4 		– Sell
-63,029
Closed -$1.16M – 9064
2019
Q3 		$1.16M Buy
63,029
+12,862
+26% +$252K ﹤0.01% 5334
2019
Q2 		$988K Buy
50,167
+2,631
+6% +$53.6K ﹤0.01% 5710
2019
Q1 		$1.09M Sell
47,536
-95,959
-67% -$2.08M ﹤0.01% 5435
2018
Q4 		$2.89M Buy
143,495
+11,365
+9% +$235K ﹤0.01% 3585
2018
Q3 		$2.87M Sell
132,130
-35,154
-21% -$781K ﹤0.01% 3800
2018
Q2 		$3.72M Buy
167,284
+27,460
+20% +$561K ﹤0.01% 3174
2018
Q1 		$2.41M Buy
139,824
+19,553
+16% +$326K ﹤0.01% 3449
2017
Q4 		$2M Buy
120,271
+32,034
+36% +$547K ﹤0.01% 3631
2017
Q3 		$1.51M Buy
88,237
+2,016
+2% +$33.9K ﹤0.01% 3762
2017
Q2 		$1.4M Buy
86,221
+40,334
+88% +$638K ﹤0.01% 3625
2017
Q1 		$796K Sell
45,887
-14,299
-24% -$239K ﹤0.01% 4339
2016
Q4 		$1.01M Buy
+60,186
New +$1M ﹤0.01% 3830
2016
Q1 		– Sell
-28,387
Closed -$345K – 6691
2015
Q4 		$345K Sell
28,387
-45,344
-61% -$558K ﹤0.01% 5019
2015
Q3 		$973K Buy
73,731
+31,960
+77% +$483K ﹤0.01% 3860
2015
Q2 		$685K Sell
41,771
-48,895
-54% -$812K ﹤0.01% 4501
2015
Q1 		$1.61M Sell
90,666
-2,228
-2% -$41.4K ﹤0.01% 3343
2014
Q4 		$1.77M Buy
92,894
+21,572
+30% +$366K ﹤0.01% 3058
2014
Q3 		$978K Buy
71,322
+48,951
+219% +$699K ﹤0.01% 3725
2014
Q2 		$365K Sell
22,371
-7,751
-26% -$112K ﹤0.01% 4788
2014
Q1 		$474K Buy
+30,122
New +$491K ﹤0.01% 4407

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Citadel Advisors's ANGO Position: Q1 2026 in Review

Citadel Advisors reduced its AngioDynamics (ANGO) stake by 5% in Q1 2026, selling an estimated $27.8K and leaving 48,322 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #9069.

Citadel Advisors first reported a position in ANGO in Q1 2014 and has held it in 41 quarters since. The position peaked at $7.95M in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Citadel Advisors held 48,322 shares of AngioDynamics worth $549K as of Q1 2026.
  • Citadel Advisors sold 2,561 AngioDynamics shares in Q1 2026, an estimated $27.8K.
  • AngioDynamics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9069 holding.
  • Citadel Advisors first reported a position in AngioDynamics in Q1 2014 and has held it in 41 quarters since.
  • Citadel Advisors's AngioDynamics position peaked at $7.95M in Q4 2023.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.